DelMar Pharmaceuticals, Inc. (DMPI)


Stock Price Forecast

Aug. 20, 2020


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading DelMar Pharmaceuticals, Inc. chart...

About the Company

DelMar Pharmaceuticals, Inc. is a clinical and biopharmaceutical company, which focuses on the development and commercialization of new cancer therapies. It pipeline includes the VAL-083. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.

Sector

Distribution Services

Industry

Wholesale Distributors

Employees

17

$M

Total Revenue

17

Employees

$10M

Market Capitalization

-0.92

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $DMPI News

KTRA Kintara Therapeutics, Inc.

14d ago, source: Seeking Alpha

Kintara Therapeutics, Inc. has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar ...

Vertex Pharmaceuticals Inc VRTX

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Decoding 15 Analyst Evaluations For Apellis Pharmaceuticals

16h ago, source:

Analysts have set 12-month price targets for Apellis Pharmaceuticals, revealing an average target of $79.4, a high estimate ...

MRNS Marinus Pharmaceuticals, Inc.

13h ago, source: Seeking Alpha

Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of therapeutic products for patients suffering from rare genetic epilepsies and other seizure ...

Catalyst Pharmaceuticals

1d ago, source: Forbes

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel medicines for patients living with rare diseases including Lambert-Eaton ...

Alnylam Pharmaceuticals

2d ago, source: Forbes

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new ...

Fennec Pharmaceuticals Inc FENC

3d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Recent Price Trend in ARS Pharmaceuticals, Inc. (SPRY) is Your Friend, Here's Why

1d ago, source:

When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is ...

These Analysts Revise Their Forecasts On ORIC Pharmaceuticals After Q4 Results

on MSN ago, source:

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported a loss for the fourth quarter on Monday. ORIC Pharmaceuticals posted a ...

Recursion Pharmaceuticals, Inc. Class A

4mon ago, source: CNN

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology ... Li on November 5, 2013 and is headquartered in Salt Lake City, UT. Mar 07 10:28am ET Recursion Pharmaceuticals Stock Has ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...